Rebecca Stevens

Rebecca Stevens

Auto-generated profile, based on publicly available information

Rebecca Stevens

Modality Platform Technologies, GSK, Stevenage, SG1 2NY, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RSRebecca Stevens
Rebecca Stevens
EBEnrique Bendito-Moll
Enrique Bendito-Moll
DBDavid J. Battersby
David J. Battersby
AMAfjal H. Miah
Afjal H. Miah
NWNatalie Wellaway
Natalie Wellaway
JHJohn D. Harling
John D. Harling

23 December 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
RSRebecca Stevens
Rebecca Stevens
HSHarry J. Shrives
Harry J. Shrives
JCJenni Cryan
Jenni Cryan
DKDiana Klimaszewska
Diana Klimaszewska
PSPeter Stacey
Peter Stacey
AMAfjal H. Miah
Afjal H. Miah
High-throughput chemistry (HTC) and direct-to-biology (D2B) platforms allow for plate-based compound synthesis and biological evaluation of crude mixtures in cellular assays. The rise of these workflows has rapidly accelerated drug-discovery programs in the field of targeted protein degradation (TPD) in recent years by removing a key bottleneck of compound purification. However, the number of chemical transformations amenable to this methodology remain minimal, leading to limitations in the exploration of chemical space using existing library-based approaches. In this work, we expanded the toolbox by synthesising a library of degraders in D2B format. First, reaction conditions are established for performing key medicinal chemistry transformations, including reductive amination, SNAr, palladium-mediated cross-coupling and alkylation, in D2B format. Second, the utility of these alternative reactions is demonstrated by rapidly identifying developable PROTACs for a range of protein targets.

10 April 2024 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
RSRebecca Stevens
Rebecca Stevens
JTJames D. F. Thompson
James D. F. Thompson
JFJulie C. L. Fournier
Julie C. L. Fournier
GBGlenn A. Burley
Glenn A. Burley
DBDavid J. Battersby
David J. Battersby
AMAfjal H. Miah
Afjal H. Miah
Targeted protein degraders such as PROTACs and molecular glues are a rapidly emerging therapeutic modality within industry and academia. Degraders possess unique mechanisms of action that lead to the removal of specific proteins by co-opting the cell's natural degradation mechanisms via induced proximity. Their optimisation thus far has often been largely empirical, requiring the synthesis and screening of a large number of analogues. In addition, the synthesis and development of degraders is often challenging, leading to lengthy optimisation campaigns to deliver candidate-quality compounds. This review highlights how the synthesis of degraders has evolved in recent years, in particular focusing on means of applying high-throughput chemistry and screening approaches to expedite these timelines, which we anticipate to be valuable in shaping the future of degrader optimisation campaigns.

3 February 2025 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
RSRebecca Stevens
Rebecca Stevens
HPHarry E. P. Palmer
Harry E. P. Palmer
AMAfjal H. Miah
Afjal H. Miah
GBGlenn A. Burley
Glenn A. Burley
Ultra high-throughput chemistry carried out in 1536-well plates is increasingly utilized for reaction optimization protocols and direct-to-biology (D2B) platforms, where nanomolar quantities of the final product are directly assessed for biochemical or cellular activity without purification. As their popularity increases, it is crucial that the synthesis of these molecules is reliable and reproducible. Research in our laboratories has identified several nuances of amide couplings when performed on the nanoscale that result in poor translation from 1536-well plates to batch-scale reactions. This case study presents a nanoscale amide coupling reaction to synthesize 700 PROTAC molecules, which identified a range of factors crucial to reaction success on the nanoscale, despite having no influence on reaction conversion in batch. This work presents a guide for high-throughput chemists to consider when working in 1536-well plates and their importance in drawing conclusions from nanoscale synthesis.